ARTICLE | Company News
Lee's Pharmaceutical, Recordati sales and marketing update
March 22, 2010 7:00 AM UTC
Recordati granted Lee's Pharmaceutical an exclusive license to market Zanidip lercanidipine in China to treat hypertension. The dihydropyridine calcium channel blocker is marketed in over 85 countries...